REPLIMUNE GROUP, INC. : Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)

Item 5.02 Departure of Directors or Certain Officers; Election of Directors;

          Appointment of Certain Officers; Compensatory Arrangements of Certain
          Officers.

On January 26, 2022, Otello Stampacchia, Ph.D., a member of the Board of Directors (the "Board") of Replimune Group, Inc. (the "Company"), notified the Board of his decision to resign as a director of the Company, effective immediately. Dr. Stampacchia's decision to resign as a director is not the result of any dispute or disagreement with the Company, its management, the Board, or any matter relating to the Company's operations, policies or practices.

Item 7.01 Regulation FD Disclosure.

On January 31, 2022, the Company issued a press release regarding Dr. Stampacchia's resignation as a director of the Company, a copy of which is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

The information contained in this Item 7.01 and in the accompanying Exhibit 99.1 shall not be incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing, unless expressly incorporated by specific reference to such filing. The information in this Item 7.01 and the accompanying Exhibit 99.1 shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended.

Item 9.01 Financial Statements and Exhibits.

Exhibit No.   Description

  99.1          News Release dated January 31, 2022
104           Cover Page Interactive Data File (embedded within the Inline XBRL document)

© Edgar Online, source Glimpses